Operating Segments and Related Information

3 Months Ended

Mar. 31, 2012

Operating Segments and Related Information [Abstract]

Segment Reporting Disclosure [Text Block]

Operating Segments and Related Information

The following table presents certain continuing operating division information in accordance with the provisions of ASC 280, “Segments Reporting.”

(in thousands)	Solar			Biomedical			Total Company
For the three months ended March 31, 2012
Net sales and revenues	$	5,853		$	1,622		$	7,475
Operating loss from continuing operations	$	(1,544	)	$	(65	)	$	(1,609	)
For the three months ended March 31, 2011
Net sales and revenues	$	15,778		$	1,950		$	17,728
Operating income (loss) from continuing operations	$	(1,486	)	$	206		$	(1,280	)

The following table shows net sales and revenues by geographic area (based on customer location):

	Three Months Ended March 31,
(in thousands)	2012		%		2011		%
United States	$	2,598	35	%	$	10,524	59	%
Europe/Africa	2,241		30		659		4
Asia	2,583		34		6,544		37
Rest of the world	53		1		1		—
	$	7,475	100	%	$	17,728	100	%

Revenues from contracts with United States government agencies for the three months ended March 31, 2012 and 2011 were approximately $424 thousand and $7.7 million or 6% and 43% of total net sales and revenues, respectively.

Revenues from the delivery of solar equipment to three customers accounted for 23%, 19% and 13%, respectively, of total net sales and revenues for the three month period ended March 31, 2012.

Revenues from the delivery of solar equipment and recurring revenues from the sale of solar cell materials to the same customer account for 1% and 41%, respectively, of total net sales and revenues for the three month period ended March 31, 2011.  Revenues from the delivery of solar equipment to one customer account for 14% of total net sales and revenues for the three month period ended March 31, 2011.

Three customers represented approximately 14%, 13% and 12%, respectively, of net accounts receivable, trade at March 31, 2012 and three customers represented approximately 21%, 13% and 11%, respectively, of net accounts receivable, trade at December 31, 2011.